AVITA Medical Announces Expanded Medicare Reimbursement to Outpatient Hospital and Ambulatory Surgical Centers
November 03, 2021 08:00 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
Regional Burn Conferences Feature 12 RECELL® System Data Presentations by Prominent Burn Surgeons
October 28, 2021 16:05 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical to Announce Fiscal First Quarter 2022 Financial Results
October 25, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Oct. 25, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical to Present at the 2021 Cantor Virtual Global Healthcare Conference
September 13, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, Sept. 13, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical to Participate at the Lake Street 2021 BIG5 Conference
August 31, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Reports Fourth Quarter and Fiscal Year 2021 Financial Results
August 26, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Aug. 26, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX:AVH) (Company), a regenerative medicine company that is developing and commercializing a technology...
FDA Approves IDE Amendment to a Single-Arm Design for AVITA Medical’s Pivotal Study of the RECELL® System for Vitiligo Treatment
August 16, 2021 08:00 ET
|
AVITA Medical
New single-arm design to evaluate 23 subjects at 15 clinical sites, versus previously approved 3-arm study of 84 subjectsThe 1:20 expansion ratio to be used is the best-case scenario for patients as...
AVITA Medical to Announce Fiscal Fourth Quarter 2021 Financial Results
August 12, 2021 16:01 ET
|
AVITA Medical
VALENCIA, Calif., and MELBOURNE, Australia, Aug. 12, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Announces Inclusion in the Russell 3000 Index
June 29, 2021 16:23 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 29, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...
AVITA Medical Announces Preliminary Fourth Quarter 2021 Financial Results
June 15, 2021 18:08 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, June 15, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing a...